TAHP Testimony Opposing SB 1122 (Applies 1919 & 1763 Rx Mandates) 3.5.25

TAHP opposes SB 1122 due to its costly mandates on employer-provided health coverage, which would add $5.4 billion in new costs over the next 10 years. The bill attempts to override federal ERISA protections, increasing costs for employers and employees while threatening the flexibility that allows businesses to offer affordable coverage.

Texas already has the fifth highest health care costs in the nation, with employer plan costs rising 16% in three years and small businesses struggling to provide coverage. SB 1122 would worsen these issues by making prescription drug coverage more expensive, reducing employer-sponsored insurance, and increasing the number of uninsured Texans.

Click here to view TAHP’s testimony opposing SB 1122.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.